Detalles de la búsqueda
1.
Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model.
Int J Cancer
; 143(2): 419-429, 2018 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29441566
2.
Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer.
Br J Cancer
; 118(6): 802-812, 2018 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29381682
3.
Subrenal capsule grafting technology in human cancer modeling and translational cancer research.
Differentiation
; 91(4-5): 15-9, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26547391
4.
Elevated expression of the centromere protein-A(CENP-A)-encoding gene as a prognostic and predictive biomarker in human cancers.
Int J Cancer
; 139(4): 899-907, 2016 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27062469
5.
Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
J Pathol
; 230(4): 350-5, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23729358
6.
Lessons from in-vivo models of castration-resistant prostate cancer.
Curr Opin Urol
; 23(3): 214-9, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23385975
7.
Epithelial immune cell-like transition (EIT): a proposed transdifferentiation process underlying immune-suppressive activity of epithelial cancers.
Differentiation
; 83(5): 293-8, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22472059
8.
Use of irinotecan for treatment of small cell carcinoma of the prostate.
Prostate
; 71(7): 675-81, 2011 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20949523
9.
Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.
Prostate
; 70(15): 1636-44, 2010 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20564316
10.
Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines.
J Pharmacol Exp Ther
; 332(3): 949-58, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20007406
11.
Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells.
Front Cell Infect Microbiol
; 9: 25, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30809511
12.
The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases.
J Cell Physiol
; 215(3): 593-602, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18181196
13.
Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts.
Front Genet
; 9: 232, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30022998
14.
Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.
Cancer Med
; 7(7): 3385-3392, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29905005
15.
Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
Eur Urol
; 73(6): 949-960, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29544736
16.
Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer.
Cancer Res
; 78(10): 2691-2704, 2018 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29487201
17.
Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.
Eur Urol
; 73(4): 524-532, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28330676
18.
Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.
Clin Cancer Res
; 12(13): 4043-54, 2006 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16818704
19.
Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of Doxorubicin.
Chemotherapy
; 53(3): 210-7, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17356269
20.
BIRC6 Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer.
Clin Cancer Res
; 23(6): 1542-1551, 2017 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27663589